Chelsea Therapeutics (CHTP) Worth Watching: Stock Surges 11%

Zacks Equity Research

Chelsea Therapeutics International Ltd. (CHTP) was a big mover last session, as the company saw its shares rise by over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up 21.4% over the past one-month time frame.

The company has seen 2 positive revisions in the past 30 days and the Zacks Consensus Estimate has moved north over the same time frame, suggesting that more solid trading could be ahead for Chelsea Therapeutics. So, be sure to keep an eye on this stock, going forward, to see if yesterday’s improvement can turn into more strength down the road.

Chelsea Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Some better performing biomedical stocks include Actelion Ltd. (ALIOF), AMAG Pharmaceuticals, Inc. (AMAG) and Acorda Therapeutics, Inc. (ACOR). While Actelion and AMAG carry a Zacks Rank #1 (Strong Buy), Acorda Therapeutics holds a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


CHELSEA THERAPEUTICS INTERNATION (CHTP): Free Stock Analysis Report

AMAG PHARMACEUTICALS INC (AMAG): Free Stock Analysis Report

ACORDA THERAPEUTICS INC (ACOR): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research